{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:01:32Z","timestamp":1790416892792,"version":"4.1.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Most studies on puberty in children born small for gestational age (SGA) report height and age at onset of puberty. GH-treated SGA children with an adult height (AH) expectation below \u22122.5 SDS at onset of puberty can benefit from an additional 2 years of GnRH analog (GnRHa) treatment. There are no data on puberty and growth after discontinuation of GnRHa treatment in GH-treated SGA children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>This study aimed to investigate the effects on puberty and pubertal growth of 2 years GnRHa vs no GnRHa in GH-treated SGA children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>This was a GH trial involving 76 prepubertal short SGA children (36 girls) treated with GH. Thirty-two children received additional GnRHa for 2 years. Pubertal stages were 3-monthly assessed according to Tanner.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Age, bone age, and median height at pubertal onset were lower in girls and boys in the GH\/GnRHa group compared with the GH group. In girls and boys treated with GH\/GnRHa, pubertal duration after stop of GnRHa treatment was shorter than pubertal duration in those with GH only (40.9 vs 46.7 mo; P = .044; 50.8 vs 57.5 months; P = .006; respectively). Height gain from onset of puberty until AH, including height gain during 2 years of GnRHa treatment, was 25.4 cm in girls and 33.0 cm in boys, which was 6.6 cm more than girls and boys treated with GH only. AH was similar in children treated with GH\/GnRHa compared with those with GH only.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>GH-treated SGA children who start puberty with an AH expectation below \u22122.5 SDS and are treated with 2 years of GnRHa have a shorter pubertal duration after discontinuation of GnRHa compared with pubertal duration in children treated with GH only. Height gain from onset of puberty until AH is, however, more due to adequate growth during 2 years of GnRHa treatment resulting in a similar AH as children treated with GH only.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2016-1317","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T04:15:13Z","timestamp":1457669713000},"page":"2005-2012","source":"Crossref","is-referenced-by-count":31,"title":["Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa"],"prefix":"10.1210","volume":"101","author":[{"given":"Manouk","family":"van der Steen","sequence":"first","affiliation":[{"name":"Dutch Growth Research Foundation (M.v.d.S., A.J.L., D.C.M.v.d.K., A.C.S.H.-K.), 3016 AH Rotterdam, The Netherlands"},{"name":"Erasmus University Medical Center\u2013Sophia Children's Hospital (M.v.d.S., A.C.S.H.-K.), 3015 CN Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J.","family":"Lem","sequence":"additional","affiliation":[{"name":"Dutch Growth Research Foundation (M.v.d.S., A.J.L., D.C.M.v.d.K., A.C.S.H.-K.), 3016 AH Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle C. M.","family":"van der Kaay","sequence":"additional","affiliation":[{"name":"Dutch Growth Research Foundation (M.v.d.S., A.J.L., D.C.M.v.d.K., A.C.S.H.-K.), 3016 AH Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C. S.","family":"Hokken-Ko\u00e8elega","sequence":"additional","affiliation":[{"name":"Dutch Growth Research Foundation (M.v.d.S., A.J.L., D.C.M.v.d.K., A.C.S.H.-K.), 3016 AH Rotterdam, The Netherlands"},{"name":"Erasmus University Medical Center\u2013Sophia Children's Hospital (M.v.d.S., A.C.S.H.-K.), 3015 CN Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614191471200_B1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.mce.2006.04.034","article-title":"Management of short stature with GnRH agonist and co-treatment with growth hormone: A controversial issue","volume":"254\u2013255","author":"Carel","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2020071614191471200_B2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/bmj.315.7104.341","article-title":"Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: Regional cohort study","volume":"315","author":"Leger","year":"1997","journal-title":"BMJ"},{"key":"2020071614191471200_B3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/oxfordjournals.aje.a010077","article-title":"Influence of perinatal factors on the onset of puberty in boys and girls: Implications for interpretation of link with risk of long term diseases","volume":"150","author":"Persson","year":"1999","journal-title":"Am J Epidemiol"},{"key":"2020071614191471200_B4","first-page":"91","article-title":"Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls","volume":"15","author":"Ghirri","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"2020071614191471200_B5","first-page":"65","article-title":"Timing of puberty and fetal growth","volume":"16","author":"Hokken-Ko\u00e8lega","year":"2002","journal-title":"Clin Endocrinol Metab"},{"key":"2020071614191471200_B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/eje.0.1490425","article-title":"Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)","volume":"149","author":"Lazar","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2020071614191471200_B7","first-page":"3064","article-title":"Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial","volume":"84","author":"Sas","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B8","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2002-021172","article-title":"Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: Results of a randomized, double-blind, dose-response GH trial","volume":"88","author":"Van Pareren","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1203\/01.PDR.0000148716.71231.81","article-title":"Final height in short children born small for gestational age treated with growth hormone","volume":"57","author":"Dahlgren","year":"2005","journal-title":"Pediatr Res"},{"key":"2020071614191471200_B10","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: Results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B11","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1210\/jc.2015-2619","article-title":"Metabolic health in short children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analog: Results of a randomized, dose-response trial","volume":"100","author":"van der Steen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B12","first-page":"jc20153435","article-title":"Insulin sensitivity and beta-cell function in SGA children treated with GH and GnRHa: Results of a long-term trial","author":"van der Steen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3476(69)80224-6","article-title":"Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation","volume":"74","author":"Usher","year":"1969","journal-title":"J Pediatr"},{"key":"2020071614191471200_B14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1203\/00006450-200003000-00006","article-title":"Continuing positive secular growth change in The Netherlands 1955\u20131997","volume":"47","author":"Fredriks","year":"2000","journal-title":"Pediatr Res"},{"key":"2020071614191471200_B15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1203\/00006450-200110000-00010","article-title":"Pubertal development in The Netherlands 1965\u20131997","volume":"50","author":"Mul","year":"2001","journal-title":"Pediatr Res"},{"key":"2020071614191471200_B16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/JPEM.2009.22.2.161","article-title":"Overnight luteinizing and follicle stimulating hormone profiles during GnRHa treatment in short girls born small for gestational age","volume":"22","author":"van der Kaay","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614191471200_B17","first-page":"260","article-title":"Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age","volume":"71","author":"van der Kaay","year":"2009","journal-title":"Horm Res"},{"key":"2020071614191471200_B18","article-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"Greulich","year":"1959","edition":"2nd ed"},{"key":"2020071614191471200_B19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"key":"2020071614191471200_B20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: Impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B21","doi-asserted-by":"crossref","first-page":"398639","DOI":"10.1186\/1687-9856-2010-398639","article-title":"Leuprolide acetate 1-month depot for central precocious puberty: Hormonal suppression and recovery","volume":"2010","author":"Neely","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"2020071614191471200_B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.6065\/apem.2014.19.1.27","article-title":"Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty","volume":"19","author":"Baek","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2020071614191471200_B23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000328117","article-title":"Growth plate senescence and catch-up growth","volume":"21","author":"Lui","year":"2011","journal-title":"Endocr Dev"},{"key":"2020071614191471200_B24","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1073\/pnas.121180498","article-title":"Effects of estrogen on growth plate senescence and epiphyseal fusion","volume":"98","author":"Weise","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071614191471200_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1680001","article-title":"Growth hormone: Roles in female reproduction","volume":"168","author":"Hull","year":"2001","journal-title":"J Endocrinol"},{"key":"2020071614191471200_B26","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1210\/jc.2003-030512","article-title":"Puberty in growth hormone-treated children born small for gestational age (SGA)","volume":"88","author":"Boonstra","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000329743","article-title":"Does growth hormone treatment influence pubertal development in short children?","volume":"76","author":"Albin","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2020071614191471200_B28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.85.2.6387","article-title":"Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone","volume":"85","author":"Pasquino","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B29","first-page":"2969","article-title":"A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation","volume":"86","author":"Kamp","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614191471200_B30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/5\/2005\/10428136\/jcem2005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/5\/2005\/10428136\/jcem2005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:56:58Z","timestamp":1594951018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/5\/2005\/2804764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-1317","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}